首页 | 本学科首页   官方微博 | 高级检索  
     


Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer
Authors:Alison T. Stopeck  Karim Fizazi  Jean-Jacques Body  Janet E. Brown  Michael Carducci  Ingo Diel  Yasuhiro Fujiwara  Miguel Martín  Alexander Paterson  Katia Tonkin  Neal Shore  Paul Sieber  Frank Kueppers  Lawrence Karsh  Denise Yardley  Huei Wang  Tapan Maniar  Jorge Arellano  Ada Braun
Affiliation:1. University of Arizona Cancer Center, Tucson, AZ, USA
2. Institut Gustave Roussy, University of Paris Sud, Villejuif, France
3. Centre Hospitalier Universitaire Brugmann, Université Libre de Bruxelles, Brussels, Belgium
4. Cancer Research UK Experimental Cancer Medicine Centres, St James’s University Hospital, Leeds, UK
5. Weston Park Hospital, University of Sheffield, Sheffield, UK
6. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA
7. Center for Comprehensive Gynecology Clinic, Mannheim, Germany
8. National Cancer Center Hospital, Tokyo, Japan
9. Instituto de Investigación Sanitaria General Gregorio Mara?ón, Universidad Complutense, Madrid, Spain
10. Tom Baker Cancer Centre, Calgary, AB, Canada
11. Cross Cancer Institute, Edmonton, AB, Canada
12. Carolina Urologic Research Center, Myrtle Beach, SC, USA
13. Lancaster Urology, Lancaster, PA, USA
14. Urology Associates, Christchurch, New Zealand
15. The Urology Center of Colorado, Denver, CO, USA
16. Sarah Cannon Research Institute, Nashville, TN, USA
17. Amgen Inc., Thousand Oaks, CA, USA
Abstract:
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号